Cellectar Biosciences differentiates itself through its proprietary PLE delivery platform, enabling selective delivery of therapeutic payloads directly to cancer cells. This precision approach supports development across multiple drug classes, with a focus on advanced cancers where treatment innovation can have the highest clinical impact. By focusing on cancers with the greatest unmet needs, we aim to deliver therapies that extend survival, reduce treatment burden, and improve quality of life for patients and their families.
Learn More About CellectarAt Cellectar, our values reflect how we advance our mission and vision. We are accountable to the patients we serve, ensuring every decision is guided by their needs. We approach challenges with resilience, knowing that progress in oncology requires persistence and precision. Our work is rooted in integrity and scientific rigor and strengthened through collaboration with partners across the healthcare community. Together, these values shape our commitment to delivering targeted therapies that make a meaningful impact for patients with advanced cancers.